These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 16789016

  • 1. Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine.
    Alexopoulou A, Dourakis SP, Pandelidaki H, Archimandritis AJ, Karayiannis P.
    J Med Virol; 2006 Aug; 78(8):1043-6. PubMed ID: 16789016
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A, Theodorou M, Dourakis SP, Karayiannis P, Sagkana E, Papanikolopoulos K, Archimandritis AJ.
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [Abstract] [Full Text] [Related]

  • 3. [Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic lymphocytic leukemia].
    Lim SM, Jang JW, Kim BW, Choi H, Choi KY, Park SJ, Han CW.
    Korean J Hepatol; 2008 Jun; 14(2):213-8. PubMed ID: 18617769
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM, Xu Y, Wang XY, Yin YK, Wu XH, Weng XH, Lu M.
    Clin Infect Dis; 2007 May 01; 44(9):1161-9. PubMed ID: 17407033
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reduced antigenicity of naturally occurring hepatitis B surface antigen variants with substitutions at the amino acid residue 126.
    Qiu S, Zhang J, Tian Y, Yang Y, Huang H, Yang D, Lu M, Xu Y.
    Intervirology; 2008 May 01; 51(6):400-6. PubMed ID: 19258718
    [Abstract] [Full Text] [Related]

  • 8. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication.
    Wu C, Zhang X, Tian Y, Song J, Yang D, Roggendorf M, Lu M, Chen X.
    J Gen Virol; 2010 Feb 01; 91(Pt 2):483-92. PubMed ID: 19812261
    [Abstract] [Full Text] [Related]

  • 9. Partial analysis of hepatitis B virus DNA from hepatocellular carcinoma showing negative hepatitis B virus surface antigen: an analysis of two Japanese cases.
    Shiota G, Oyama K, Udagawa A, Nomi T, Tanaka K, Tsutsumi A, Noguchi N, Okano J, Kishimoto Y, Kanbe T, Kishimoto H, Kawasaki H.
    Hepatogastroenterology; 2009 Feb 01; 56(94-95):1516-20. PubMed ID: 19950820
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus.
    Sayiner AA, Ozcan A, Sengonul A.
    J Med Virol; 2008 Mar 01; 80(3):405-10. PubMed ID: 18205223
    [Abstract] [Full Text] [Related]

  • 13. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor.
    Datta S, Banerjee A, Chandra PK, Chakraborty S, Basu SK, Chakravarty R.
    J Clin Virol; 2007 Nov 01; 40(3):255-8. PubMed ID: 17869170
    [Abstract] [Full Text] [Related]

  • 14. Analysis of hepatitis B surface antigen mutations in Mongolia: molecular epidemiology and implications for mass vaccination.
    Davaalkham D, Ojima T, Uehara R, Watanabe M, Oki I, Endo K, Takahashi M, Okamoto H, Nakamura Y.
    Arch Virol; 2007 Nov 01; 152(3):575-84. PubMed ID: 17115304
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan 01; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 18. Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab.
    Sanchez MJ, Buti M, Homs M, Palacios A, Rodriguez-Frias F, Esteban R.
    J Hepatol; 2009 Dec 01; 51(6):1091-6. PubMed ID: 19836097
    [Abstract] [Full Text] [Related]

  • 19. Mutation spectra of the surface-protein-coding region of the HBV genome in HBV-vaccinated and non-vaccinated individuals in Hungary.
    Szomor KN, Dencs A, Garai E, Rusvai E, Berencsi G, Takács M.
    Arch Virol; 2008 Dec 01; 153(10):1885-92. PubMed ID: 18813870
    [Abstract] [Full Text] [Related]

  • 20. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.
    Matsubara N, Kusano O, Sugamata Y, Itoh T, Mizuii M, Tanaka J, Yoshizawa H.
    Transfusion; 2009 Mar 01; 49(3):585-95. PubMed ID: 19192255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.